12-23-2008: Seegene, Inc announced that it has been awarded international patent protection for a break-through technology able to accelerate the detection of highly personal variations in genetic sequences. These genetic variations can identify an individual's risks for a broad range of disorders, such as Alzheimer's disease and coronary artery diseases, or genetic mutations known to cause various cancers.
The patent (WO/2008/143367) issued by the World Intellectual Property Organization covers a novel method for ApoE haplotyping using multiplex PCR. Seegene's proprietary Dual Priming Oligonucleotide (DPO(TM)) technology is being applied to haplotyping - the investigation of the genetic background and phenotype structures of complex diseases.
According to Jong-Yoon Chun, Founder and Chief Executive Officer, Seegene, "This novel approach to haplotyping using the Seegene multiplex platform allows biomedical researchers to cross a barrier that to this point has frustrated many - the exploration of observed patterns of genetic sequences that help us understand how the diverse traits reveal themselves as true risks for individuals."
Contact / Request information
Request further information free of charge:
Seegene and Molzym partner on automated molecular sepsis diagnostics
Seegene and Molzym announced a partnership on the automated Magicplex™ Sepsis, a new multi-pathogen screening test capable of quick and accurate identification of over 90 leading sepsis-causing pathogens. "The Magicplex Sepsis Test will be the new gold standard for performing accurate, rapi ... more
Seegene Awarded Patent for Haplotyping Using Multiplex PCR
Seegene, Inc announced that it has been awarded international patent protection for a break-through technology able to accelerate the detection of highly personal variations in genetic sequences. These genetic variations can identify an individual's risks for a broad range of disorders, suc ... more
Seegene and Shimadzu Agree to Join Multi-Pathogen Tests and Platform for Combined Analytics Solution
Seegene, Inc. and Shimadzu Corporation announced a strategic partnership to combine Seegene's Seeplex(R) multi-pathogen tests with Shimadzu's MultiNA (1) analytical platform. Under terms of the deal, Shimadzu and Seegene will collaborate on integrating the Seeplex polymerase chain reaction- ... more
About analytica-world.com
analytica-world.com is the industry portal of the international trade fair analytica, which is organized by Messe München. It features useful information about markets, trends and innovations. It is operated by CHEMIE.DE, one of analytica's official sales partners.
Advertising at analytica-world.com
Our advertising formats support you in getting your message across to a clearly defined target audience.
The global network of analytica trade fairs:
